Skip to main content
. 2019 Mar 13;42(4):321–332. doi: 10.14348/molcells.2019.2441

Table 2.

Expression of IGFBP3 in different tissues

Control Non-metastatic primary Other-metastatic primary Brain-metastatic primary Brain metastases
2/15 (13.3%) 5/15 (33.3%) 9/15 (60%) 8/10 (80%) 7/8 (83.33%)